|RFx ID :||8485466|
|Tender Name :||Haemophilia Treatments RFP|
|Reference # :||A30901|
|Open Date :||Monday, 2 February 2015 4:00 PM (Pacific/Auckland UTC+13:00)|
|Close Date :||Friday, 6 March 2015 5:00 PM (Pacific/Auckland UTC+13:00)|
|Tender Type :||Request for Proposals (RFP)|
|Tender Coverage :||Sole Agency [?]|
|Exemption Reason :||None|
|Required Pre-qualifications :||None|
Sue Anne Yee
|Alternate Physical Delivery Address :|
|Alternate Physical Fax Number :|
PHARMAC invites proposals for the supply of Recombinant Factor VIII, Recombinant Factor IX, Recombinant Factor VIIa and/or Factor VIII inhibitor bypassing fraction, in New Zealand (community and DHB hospitals).
This request for proposals (RFP) letter incorporates the following schedules:
• Schedule 1 specifies the pharmaceuticals for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
• Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
• Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceuticals; and
• Schedule 4 contains the RFP form in which you are to provide details of your proposal.
All proposals must be submitted to PHARMAC via the Government Electronic Tenders Service (GETS) no later than 5pm (New Zealand time) on Friday, 6 March 2015.